Activation-induced apoptosis in human macrophages: Developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon γ

Journal of Experimental Medicine

Volumn 181, Issue 1, 1995, Pages 127-136

  Munn, David H ^a   Beall, Arthur C ^a   Song, Danny ^a   Wrenn, Robert W ^a   Throckmorton, Douglas C ^a  

^a Medical College of Georgia in Augusta   (Georgia)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR RECEPTOR; GAMMA INTERFERON; MONOCLONAL ANTIBODY; PHORBOL ESTER; STAUROSPORINE; ZYMOSAN;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOREGULATION; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; SEPTIC SHOCK;

APOPTOSIS; DNA DAMAGE; ENZYME ACTIVATION; HUMAN; IN VITRO; INTERFERON TYPE II; MACROPHAGE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICROSCOPY, ELECTRON; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPPORT, NON-U.S. GOV'T; TETRADECANOYLPHORBOL ACETATE;

EID: 0028955622     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.181.1.127     Document Type: Article

References (63)

1. Scott, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science (Wash. DC). 260: 496-497.
2. Solbach, W., H. Moll, and M. Rollinghoff. 1991. Lymphocytes play the music but macrophages call the tune. Immunol. Today. 12: 4-6.
3. Small, P.L.C., L. Ramakrishnan, and S. Falkow. 1994. Remodeling schemes of intracellular pathogens. Science (Wish. DC). 263: 637-639.
4. Lewis, D.B., and C.B. Wilson. 1990. Gamma-interferon: an immunoregulatory lymphokine with immunotherapeutic potential. Pediatr. Infect. Dis. J. 9: 642-651.
5. Kamijo, R., J. Le, D. Shapiro, E.A. Havell, S. Huang, M. Aguet, M. Bosland, and J. Vilcek. 1993. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J. Exp Med. 178: 1435-1440.
6. Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, and T.A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science (Wash. DC). 259: 1739-1742.
7. Nathan, C.F., H.W. Murray, and Z.A. Cohn. 1980. Current concepts. The macrophage as an effector cell. N. Engl.J. Med. 303: 622-626.
8. Cerami, A. 1992. Inflammatory cytokines. Clin. Immunol. Immunopathol. 62: S3-S10.
9. Car, B.D., V.M. Eng, B. Schnyder, L. Ozmen, S. Huang, P. Gallay, D. Heumann, M. Aguet, and B. Ryffel. 1994. Interferon gamma receptor-deficient mice are resistant to endotoxic shock. J. Exp. Med. 179: 1437-1444.
10. Reed, J.C. 1994. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124: 1-5.
11. MacDonald, H.R., and R.K. Kees. 1990. Programmed death of autoreactive thymocytes. Nature (Lond.). 343: 642-644.
12. Wesselborg, S., O. Janssen, and D. Kabelitz. 1993. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 150: 4338-4345.
13. Radvanyi, L.G., G.B. Mills, and R.G. Miller. 1993. Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J. Immunol. 150: 5704-5715.
14. McDonnell, T.J., N. Deane, F.M. Platt, G. Nunez, U. Jaeger, J.P. McKeam, and S.J. Korsmeyer. 1989. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 57: 79-88.
15. Nisitani, S., T. Tsubata, M. Murakami, M. Okamoto, and T. Honjo. 1993. The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J. Exp Med. 178: 1247-1254.
16. Haslet, C. 1992. Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin. Sci. (Lond.). 83: 639-648.
17. Mangan, D.F., G.R. Welch, and S.M. Wahl. 1991. Lipopolysaccharide, tumor necrosis factor-alpha, and IL-l-beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J. Immunol. 146: 1541-1546.
18. Mangan, D.F., and S.M. Wahl. 1991. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J. Immunol. 147: 3408-3412.
19. Van Furth, R. 1988. Phagocytic cells: development and distribution of mononuclear phagocytes in normal steady state and inflammation. In Inflammation: Basic Principles and Clinical Correlates. J.I. Gallin, I.M. Goldstein, and R. Snyderman, editors. Raven Press, Ltd., New York. 218-295.
20. Munn, D.H., and E. Armstrong. 1993. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by interferon-gamma. Cancer Res. 53: 2603-2613.
21. Fogelman, A.M., J. Seeger, P.A. Edwards, M. Hokom, and G. Popjak. 1977. Cholesterol biosynthesis in human lymphocytes, monocytes, and granulocytes. Biochem. Biophys. Res. Commun. 76: 167-173.
22. Munn, D.H., and N.-K.V. Cheung. 1990. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor. J. Exp Med. 172: 231-237.
23. Munn, D.H., M. McBride, and N.-K.V. Cheung. 1991. Role of low-affinity Fc receptors in antibody-dependent tumor cell phagocytosis by monocyte-derived macrophages. Cancer Res. 51: 1117-1123.
24. Munn, D.H., and N.-K.V. Cheung. 1989. Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays. J. Exp Med. 170: 511-526.
25. Pick, E. 1986. Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassay microplate reader. Methods Enzymol, 132: 407-421.
26. Downs, T.R., and W.W. Wilfinger. 1983. Fluorometric quantitation of DNA in cells and tissues. Anal. Biochem. 131: 538-547.
27. Zakeri, Z.A., D. Quaglino, T. Latham, and R.A. Lockshin. 1993. Delayed internucleosomal DNA fragmentation in programmed cell death. FASEB (Fed. Am. Soc Exp. Biol.) J. 7: 470-478.
28. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119: 493-501.
29. Telford, W.G., L.E. King, and P.J. Fraker. 1992. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry. 13: 137-143.
30. Nathan, C.F., and R.K. Root. 1977. Hydrogen peroxide release from mouse peritoneal macrophages: dependence on sequential activation and triggering. J. Exp Med. 146: 1648-1662.
31. Damiani, P., and G. Burdini. 1986. Fluorescent assay for nitrite. Talanta. 33: 649-652.
32. Wrenn, R.W., M.G. Currie, and L.E. Herman. 1994. Nitric oxide participates in the regulation of pancreatic acinar cell secretion. Life Sci. 55: 511-518.
33. Marczin, N., U.S. Ryan, and J.D. Catravas. 1992. Endothelial cGMP does not regulate basal release of endothelium-derived relaxing factor in culture. Am. J. Physiol. 263: L113-L121.
34. Pezzella, F., A.G.D. Tse, J.L. Cordell, K.A.F. Pulford, K.C. Gatter, and D.Y. Mason. 1990. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am. J. Pathol. 137: 225-232.
35. Tamaru, Y., T. Miyawaki, K. Iwai, T. Tsuji, R. Nibu, A. Yachie, S. Koizumi, and N. Taniguchi. 1993. Absence of bcl-2 expression by activated CD45RO+ T lymphocytes in acute infectious mononucleosis supporting their susceptibility to programmed cell death. Blood. 82: 521-527.
36. Timmons, T.M., and B.S. Dunbar. 1990. Protein blotting and immunodetection. Methods Enzymol. 182: 679-688.
37. Yasuda, I., A. Kishimoto, S.-I. Tanaka, A. Tominaga, and Y. Nishizuka. 1990. A synthetic peptide substrate for selective assay of protein kinase C. Biochem. Biophys. Res. Commun. 166: 1220-1227.
38. Wooten, M.W., and R.W. Wrenn. 1985. Redistribution of phospholipid/calcium-dependent protein kinase and altered phosphorylation of its soluble and particulate substrate proteins in phorbol ester-treated rat pancreatic acini. Cancer Res. 45: 3912-3917.
39. Ducommun, B., and D. Beach. 1990. A versatile microtiter assay for the universal cdc2 cell cycle regulator. Anal. Biochem. 187: 94-97.
40. Ganesan, S., R. Calle, K. Zawalich, J.I. Smallwook, W.S. Zawalich, and H. Rasmussen. 1990. Glucose-induced translocation of protein kinase C in rat pancreatic islets. Proc. Natl. Acad. Sci. USA. 87: 9893-9897.
41. Arends, M.J., R.G. Morris, and A.H. Wyllie. 1990. Apoptosis: the role of the endonuclease. Am.J. Pathol. 136: 593-608.
42. Brown, D.G., X.M. Sun, and G.M. Cohen. 1993. Dexamethasone-Induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J. Biol. Chem. 268: 3037-3039.
43. Wyllie, A.H., J.F.R. Kerr, and A.R. Currie. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68: 251-306.
44. Ivanov, V., M. Merkenschlager, and R. Ceredig. 1993. Antioxidant treatment of thymic organ cultures decreases NF-kB and TCFl(alpha) transcription factor activities and inhibits alpha-beta T cell development. J. Immunol. 151: 4694-4704.
45. Ziegler-Heitbrock, H.W.L., T. Sternsdorf, J. Liese, B. Belohradsky, C. Weber, A. Wedel, R. Schreck, P. Bauerle, and M. Stroebel. 1993. Pyrrolidine dithiocarbamate inhibits NF-kB mobilization and TNF production in human monocytes. J. Immunol. 151: 6986-6993.
46. Meyer, M., R. Schreck, and P.A, Baeuerle. 1993. H2O2 and antioxidants have opposite effects on activation of NF-kB and AP-1 in intact cells: AP-1 as secondary anti-oxidant-responsive factor. EMBO (Eur. Mol. Biol. Organ.) J. 5: 2005-2015.
47. Nakagawara, A., C.F. Nathan, and Z.A. Cohn. 1981. Hydrogen peroxide metabolism in human monocytes during differentiation in vivo. J. Clin. Invest. 68: 1243-1252.
48. Zidovetzki, R., and D.S. Lester. 1992. The mechanism of activation of protein kinase C: a biophysical perspective. Biochim. Biophys. Acta. 1134: 261-272.
49. Li, Q., and M.K. Cathcart. 1994. Protein kinase C activity is required for lipid oxidation of low density lipoprotein by activated human monocytes. J. Biol. Chem. 269: 17508-17515.
50. Ryves, W.J., A.T. Evans, A.R. Olivier, P.J. Parker, and F.J. Evans. 1991. Activation of the PKC-Isotypes alpha, beta 1, gamma, zeta and epsilon by phorbol esters of different biological activities. FEBS (Fed. Eur. Biochem. Soc) Lett. 288: 5-9.
51. Tamaoki, T. 1991. Use and specificity of staurosporine, UCN-01, and calphostin C as protein kinase inhibitors. Methods Enzymol. 201: 340-347.
52. McConkey, D.J., S. Orrenius, and M. Jondal. 1990. Cell signalling in programmed cell death (apoptosis). Immunol. Today. 11: 120-121.
53. Kizaki, H., T. Tadakuma, C. Odaka, J. Muramatsu, and Y. Ishimura. 1989. Activation of a suicide process of thymocytes through DNA fragmentation by calcium ionophores and phorbol esters. J. Immunol. 143: 1790-1794.
54. Day, M.L., X. Zhao, S. Wu, P.E. Swanson, and P.A. Humphrey. 1994. Phorbol ester-induced apoptosis is accompanied by NGFI-A and c-fos activation in androgen-sensitive prostate cells. Cell Growth Differ. 5: 735-741.
55. Uckun, F.M., G.L. Schieven, L.M. Tuel-Ahlgren, I. Dibirdik, D.E. Meyers, J.A. Ledbetter, and C.W. Song. 1993. Tyrosine phosphorylation is a mandatory proximal step in radiation-induced activation of the protein kinase C signaling pathway in human B-lymphocyte precursors. Proc Natl. Acad. Sci. USA. 90: 252-256.
56. Hug, H., and T.F. Sarre. 1993. Protein kinase C isoenzymes: divergence in signal transduction? Biochem. J. 291: 329-343.
57. Mischak, H., J.H. Pierce, J. Goodnight, M.G. Kazanietz, P.M. Blumberg, and J.F. Mushinski. 1993. Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-alpha and-delta and not by protein kinase C-betall, epsilon, zeta, and eta. J. Biol. Chem. 268: 20110-20115.
58. Oltvai, Z.N., C.L. Milliman, and S.J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programed cell death. Cell. 74: 609-619.
59. Boise, L.H., M. Gonzalez-Garcia, C.E. Postema, L. Ding, T. Lindsten, L.A. Turka, X. Mao, G. Nunez, and C.B. Thompson. 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74: 597-608.
60. Hockenbery, D.M., Z.N. Oltvai, X.-M. Yin, C.L. Milliman, and S.J. Korsmeyer. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75: 241-251.
61. Albina, E.A., S. Cui, R.B. Mateo, and J.S. Reichner. 1993. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150: 5080-5085.
62. Nussler, A.K., and T.R. Billiar. 1993. Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukocyte Biol. 54: 171-178.
63. Marrack, P., and J. Kappler. 1994. Subversion of the immune system by pathogens. Cell. 76: 323-332.